West Pharmaceutical Services, Inc.
WST
$259.79
-$19.62-7.02%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.97% | 9.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.97% | 9.81% | |||
| Cost of Revenue | 3.59% | 5.69% | |||
| Gross Profit | 7.45% | 18.11% | |||
| SG&A Expenses | 6.98% | 9.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | 0.00% | |||
| Total Operating Expenses | 3.68% | 6.53% | |||
| Operating Income | 9.88% | 24.32% | |||
| Income Before Tax | 7.41% | 42.23% | |||
| Income Tax Expenses | 12.58% | 25.31% | |||
| Earnings from Continuing Operations | 6.22% | 46.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.22% | 46.77% | |||
| EBIT | 9.88% | 24.32% | |||
| EBITDA | 8.64% | 19.38% | |||
| EPS Basic | 6.22% | 47.38% | |||
| Normalized Basic EPS | 7.74% | 24.48% | |||
| EPS Diluted | 5.49% | 47.97% | |||
| Normalized Diluted EPS | 7.60% | 24.81% | |||
| Average Basic Shares Outstanding | 0.00% | -0.41% | |||
| Average Diluted Shares Outstanding | 0.14% | -0.68% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.06% | -0.32% | |||